Clinical Trial Update: Arsenic Trioxide With Cyclophosphamide in Patients With Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated arsenic trioxide in combination with cyclophosphamide in patients with relapsed/refractory acute myeloid leukemia. The study was termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Acute Myeloid Leukemia, Relapsed/Refractory Acute Myeloid Leukemia | Phase 1 | Status: TERMINATED | Results posted: 2024-08-01